Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
J BUON. 2021 Mar-Apr;26(2):645.
The Editors of JBUON issue an Expression of Concern to 'Antitumor effects of flavokawain-B flavonoid in gemcitabine resistant lung cancer cells are mediated via mitochondrial mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K/AKT Signaling pathway', by Rong Hua, Yaofei Pei, Haiyong Gu, Yifeng Sun, Yi He, JBUON 2020;25(1):262-267; PMID: 32277640. Following the publication of the above article, readers drew to our attention that part of the data was possibly unreliable. We sent emails to the authors with a request to provide the raw data to prove the originality, but received no reply. Therefore, as we continue to work through the issues raised, we advise readers to interpret the information presented in the article with due caution. We thank the readers for bringing this matter to our attention. We apologize for any inconvenience it may cause.
JBUON 杂志编辑发布了对 Rong Hua、Yaofei Pei、Haiyong Gu、Yifeng Sun 和 Yi He 发表的题为“ flavokawain-B 类黄酮在吉西他滨耐药肺癌细胞中的抗肿瘤作用是通过线粒体介导的细胞凋亡、ROS 产生、细胞迁移和细胞侵袭抑制以及阻断 PI3K/AKT 信号通路介导的”一文的关注声明的关注。该文发表在 JBUON 2020 年第 25 卷第 1 期:262-267 页;PMID: 32277640。在发表上述文章后,读者提请我们注意部分数据可能不可靠。我们向作者发送了电子邮件,要求他们提供原始数据以证明其原创性,但未收到回复。因此,在我们继续处理提出的问题时,我们建议读者谨慎解读该文章中呈现的信息。我们感谢读者对此事的关注。我们对由此可能造成的任何不便表示歉意。